A carregar...
Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer
In the past decade, a shift toward targeted therapies in non-small-cell lung cancer following molecular profiling has dramatically changed the way advanced adenocarcinoma is treated. However, tumor cells inevitably acquire resistance to such therapies, circumventing any sustained clinical benefit. A...
Na minha lista:
| Publicado no: | J Mol Med (Berl) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5696571/ https://ncbi.nlm.nih.gov/pubmed/24852181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00109-014-1165-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|